Navigation Links
Emerging Pharmaceutical Markets Globally
Date:11/14/2011

NEW YORK, Nov. 14, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Emerging Pharmaceutical Markets Globally

http://www.reportlinker.com/p0187762/Emerging-Pharmaceutical-Markets-Globally.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical

The growth in pharma markets in developing countries with emerging economies (E7 countries) has outpaced the overall growth of the global pharma market. The factors including rapidly growing economies of these countries, increasing per capita income, increasing prevalence of lifestyle diseases, and low-cost are driving the pharma markets in these countries with a fast pace. In 2010, pharma market in E7 countries (Brazil, Russia, China, India, Turkey, Mexico, and Indonesia) was estimated at around US$ 136 Billion, and it is expected to achieve a high growth during 2011-2014, thereby increasing their share in global pharma market.

According to our new research study on the sector titled, "Emerging Pharmaceutical Markets Globally", the pharmaceutical market in the abovementioned emerging countries is projected to grow at a double digit CAGR during 2011-2014. Currently, these markets are characterized by rapid urbanization with a change in lifestyle leading to the growth in prevalence of lifestyle diseases.

Our report has found that China has the largest pharma market out of these seven countries, followed by India, Brazil, and Russia. The maximum growth in future is expected to be in China and India due to strong government support and increasing aging population. Besides, we have identified that the prevalence of chronic diseases will remain one of the major drivers for the pharmaceutical market in the E7 counties. Growing pharma industry in emerging countries are also providing immense opportunity for contract research and manufacturing to flourish at rapid pace.

The research study provides extensive and coherent information about pharma markets in the E7 countries. It highlights several emerging opportunities growing in-line with development of pharma markets in E7 countries. The research study provides detailed statistical and analytical review on demographics, macroeconomic indicators, and disease profile. It contains all the key details that will help clients to draw up market strategies and assess opportunity areas for their success in these emerging pharma markets.

1. Analyst View

2. Research Methodology

3. Global Pharmaceutical Market

3.1 Market Size

3.2 Mature Markets - G7 Countries

3.3 Emerging Markets - E7 Countries

3.4 E7 Countries to Grow Strongly

4. Why E7 Pharmaceutical Market?

4.1 Economic Growth

4.2 Income Level

4.3 Population Base

4.4 Medical & Distribution Infrastructure

4.5 Health Insurance

5. Industry Performance

5.1 Brazil (Past, Present & Future Scenario)

5.1.1 Macroeconomic Indicators

5.1.2 Population Profile

5.1.3 Disease Profile

5.1.4 Healthcare Spending & Financing

5.1.5 Pharmaceutical Market

5.1.6 Import & Export

5.1.7 Branded & Generic Drugs

5.1.8 Key Players

5.2 Russia (Past, Present & Future Scenario)

5.2.1 Macroeconomic Indicators

5.2.2 Population Profile

5.2.3 Disease Profile

5.2.4 Healthcare Spending & Financing

5.2.5 Pharmaceutical Market

5.2.6 Import

5.2.7 Key Players

5.3 India (Past, Present & Future Scenario)

5.3.1 Macroeconomic Indicators

5.3.2 Population Profile

5.3.3 Disease Profile

5.3.4 Healthcare Spending & Financing

5.3.5 Pharmaceutical Market

5.3.6 Import & Export

5.3.7 Branded & Generic Drugs

5.3.8 Key Players

5.4 China (Past, Present & Future Scenario)

5.4.1 Macroeconomic Indicators

5.4.2 Population Profile

5.4.3 Disease Profile

5.4.4 Healthcare Spending & Financing

5.4.5 Pharmaceutical Market

5.4.6 Import & Export

5.4.7 Branded & Generic Drugs

5.4.8 Key Players

5.5 Turkey (Past, Present & Future Scenario)

5.5.1 Macroeconomic Indicators

5.5.2 Population Profile

5.5.3 Disease Profile

5.5.4 Healthcare Spending & Financing

5.5.5 Pharmaceutical Market

5.5.6 Import & Export

5.5.7 Branded & Generic Drugs

5.5.8 Key Players

5.6 Mexico (Past, Present & Future Scenario)

5.6.1 Macroeconomic Indicators

5.6.2 Population Profile

5.6.3 Disease Profile

5.6.4 Healthcare Spending & Financing

5.6.5 Pharmaceutical Market

5.6.6 Import & Export

5.6.7 Branded & Generic Drugs

5.6.8 Key Players

5.7 Indonesia (Past, Present & Future Scenario)

5.7.1 Macroeconomic Indicators

5.7.2 Population Profile

5.7.3 Disease Profile

5.7.4 Healthcare Spending & Financing

5.7.5 Pharmaceutical Market

5.7.6 Import & Export

5.7.7 Branded & Generic Drugs

5.7.8 Key Players

6. Opportunities

6.1 Chronic Diseases

6.2 Pharma Outsourcing Market

6.3 Vaccine Market

7. Restraining Forces

7.1 Counterfeit Drugs

7.2 Patent Protection

7.3 Traditional Medicines

8. Key Players

8.1 GlaxoSmithKline

8.2 Sanofi-Aventis

8.3 Pfizer Inc.

8.4 Novartis

8.5 AstraZeneca

List of Figures:

Figure 3-1: Global - Pharmaceutical Market (Billion US$), 2009-2014

Figure 3-2: G7 Countries - Pharmaceutical Market (Billion US$), 2010

Figure 3-3: G7 Countries - Forecast for Pharmaceutical Market (Billion US$), 2014

Figure 3-4: G7 Countries - Forecast for Growth of Pharmaceutical Market (%), 2011 to 2014

Figure 3-5: E7 Countries - Pharmaceutical Market (Billion US$), 2010

Figure 3-6: E7 Countries - Forecast for Pharmaceutical Market (Billion US$), 2014

Figure 3-7: E7 Countries - Forecast for Growth of Pharmaceutical Market (%), 2011 to 2014

Figure 3-8: Global - Share of E7 & G7 Countries in Pharmaceutical Market (2010 & 2014)

Figure 4-1: G7 & E7 Countries - Nominal GDP (Trillion US$), 2010 & 2014

Figure 4-2: Global - Share of E7 & G7 Countries Population in Total Population (2010 & 2014)

Figure 4-3: Relative Per Capita Spending on Drugs by Age Group

Figure 5-1: Brazil - Nominal GDP (Billion US$), 2009-2014

Figure 5-2: Brazil - Consumer Price Index (%), 2009-2014

Figure 5-3: Brazil - Foreign Direct Investment (Billion US$), 2009 & 2010

Figure 5-4: Brazil - Population (Million), 2009-2014

Figure 5-5: Brazil - Breakup of Population by Age Group (%), 2009-2014

Figure 5-6: Brazil - Population in the Age Group of 65 Years & Above (Million), 2009-2014

Figure 5-7: Brazil - Breakup of Deaths by Various Causes (%), 2010

Figure 5-8: Brazil - Per Head Healthcare Spending (US$), 2009-2014

Figure 5-9: Brazil - Breakup of Healthcare Payment by Source (%), 2010

Figure 5-10: Brazil - Pharmaceutical Market (Billion US$), 2009-2014

Figure 5-11: Brazil - Pharmaceutical Imports (Billion US$), 2009 & 2010

Figure 5-12: Brazil - Pharmaceutical Exports (Billion US$), 2009 & 2010

Figure 5-13: Brazil - Generic Drugs Market (Billion US$), 2009 & 2010

Figure 5-14: Brazil - Share of Branded & Generic Drugs in Pharmaceutical Market (2010)

Figure 5-15: Russia - Nominal GDP (Billion US$), 2009-2014

Figure 5-16: Russia - Consumer Price Index (%), 2009-2014

Figure 5-17: Russia - Foreign Direct Investment (Billion US$), 2009 & 2010

Figure 5-18: Russia - Population (Million), 2009-2014

Figure 5-19: Russia - Breakup of Population by Age Group (%), 2009-2014

Figure 5-20: Russia - Population in the Age Group of 65 Years & Above (Million), 2009-2014

Figure 5-21: Russia - Breakup of Deaths by Various Causes (%), 2010

Figure 5-22: Russia - Per Head Healthcare Spending (US$), 2009-2014

Figure 5-23: Russia - Breakup of Healthcare Payment by Source (%), 2010

Figure 5-24: Russia - Pharmaceutical Market (Billion US$), 2009-2014

Figure 5-25: Russia - Pharmaceutical Imports (Billion Rubles), 2009 & 2010

Figure 5-26: India - Nominal GDP (Billion US$), 2009-2014

Figure 5-27: India - Consumer Price Index (%), 2009-2014

Figure 5-28: India - Foreign Direct Investment (Billion US$), FY 2009 & FY 2010

Figure 5-29: India - Foreign Direct Investment in Pharmaceutical Market (Million US$), FY 2009 & FY 2010

Figure 5-30: India - Population (Million), 2009-2014

Figure 5-31: India - Breakup of Population by Age Group (%), 2009-2014

Figure 5-32: India - Population in the Age Group of 65 Years & Above (Million), 2009-2014

Figure 5-33: India - Breakup of Deaths by Various Causes (%), 2010

Figure 5-34: India - Per Head Healthcare Spending (US$), 2009-2014

Figure 5-35: India - Breakup of Healthcare Payment by Source (%), 2010

Figure 5-36: India - Pharmaceutical Market (Billion US$), FY 2009 to FY 2014

Figure 5-37: India - Pharmaceutical Imports (Billion INR), FY 2009 & FY 2010

Figure 5-38: India - Pharmaceutical Exports (Billion INR), FY 2009 & FY 2010

Figure 5-39: India - Breakup of Domestic Pharmaceutical Market by Segment (%), 2010

Figure 5-40: China - Nominal GDP (Billion US$), 2009-2014

Figure 5-41: China - Consumer Price Index (%), 2009-2014

Figure 5-42: China - Foreign Direct Investment (Billion US$), 2009 & 2010

Figure 5-43: China - Population (Million), 2009-2014

Figure 5-44: China - Breakup of Population by Age Group (%), 2009-2014

Figure 5-45: China - Population in the Age Group of 65 Years & Above (Million), 2009-2014

Figure 5-46: China - Breakup of Deaths by Various Causes (%), 2010

Figure 5-47: China - Per Head Healthcare Spending (US$), 2009-2014

Figure 5-48: China - Breakup of Healthcare Payment by Source (%), 2010

Figure 5-49: China - Pharmaceutical Market (Billion US$), 2009-2014

Figure 5-50: China - Pharmaceutical Imports (Billion US$), 2009 & 2010

Figure 5-51: China - Pharmaceutical Exports (Billion US$), 2009 & 2010

Figure 5-52 China - Share of Generic Drugs in Pharmaceutical Market (2010)

Figure 5-53: Turkey - Nominal GDP (Billion US$), 2009-2014

Figure 5-54: Turkey - Consumer Price Index (%), 2009-2014

Figure 5-55: Turkey - Foreign Direct Investment (Billion US$), 2009 & 2010

Figure 5-56: Turkey - Population (Million), 2009-2014

Figure 5-57: Turkey - Breakup of Population by Age Group (%), 2009-2014

Figure 5-58: Turkey - Population in the Age Group of 65 Years & Above (Million), 2009-2014

Figure 5-59: Turkey - Breakup of Deaths by Various Causes (%), 2010

Figure 5-60: Turkey - Per Head Healthcare Spending (US$), 2009-2014

Figure 5-61: Turkey - Breakup of Healthcare Payment by Source (%), 2010

Figure 5-62: Turkey - Pharmaceutical Market (Billion €), 2009-2014

Figure 5-63: Turkey - Share of Imported & Domestically Manufactured Drugs in Pharmaceutical Market (2010)

Figure 5-64: Turkey - Pharmaceutical Exports (Million US$), 2009 & 2010

Figure 5-65: Turkey - Share of Branded & Generic Drugs in Pharmaceutical Market by Value (2010)

Figure 5-66: Turkey - Share of Branded & Generic Drugs in Pharmaceutical Market by Volume (2010)

Figure 5-67: Mexico - Nominal GDP (Billion US$), 2009-2014

Figure 5-68: Mexico - Consumer Price Index (%), 2009-2014

Figure 5-69: Mexico - Foreign Direct Investment (Billion US$), 2009 & 2010

Figure 5-70: Mexico - Population (Million), 2009-2014

Figure 5-71: Mexico - Breakup of Population by Age Group (%), 2009-2014

Figure 5-72: Mexico - Population in the Age Group of 65 Years & Above (Million), 2009-2014

Figure 5-73: Mexico - Breakup of Deaths by Various Causes (%), 2010

Figure 5-74: Mexico - Per Head Healthcare Spending (US$), 2009-2014

Figure 5-75: Mexico - Breakup of Healthcare Payment by Source (%), 2010

Figure 5-76: Mexico - Pharmaceutical Market (Billion US$), 2009-2014

Figure 5-77: Mexico - Pharmaceutical Imports (Million US$), 2009 & 2010

Figure 5-78: Mexico - Pharmaceutical Exports (Million US$), 2009 & 2010

Figure 5-79: Mexico - Share of Branded & Generic Drugs in Pharmaceutical Market (2010)

Figure 5-80: Indonesia - Nominal GDP (Billion US$), 2009-2014

Figure 5-81: Indonesia - Consumer Price Index (%), 2009-2014

Figure 5-82: Indonesia - Foreign Direct Investment (Billion US$), 2009 & 2010

Figure 5-83: Indonesia - Population (Million), 2009-2014

Figure 5-84: Indonesia - Breakup of Population by Age Group (%), 2009-2014

Figure 5-85: Indonesia - Population in the Age Group of 65 Years & Above (Million), 2009-2014

Figure 5-86: Indonesia - Breakup of Deaths by Various Causes (%), 2010

Figure 5-87: Indonesia - Per Head Healthcare Spending (US$), 2009-2014

Figure 5-88: Indonesia - Breakup of Healthcare Payment by Source (%), 2010

Figure 5-89: Indonesia - Pharmaceutical Market (Billion US$), 2009-2014

Figure 5-90: Indonesia - Pharmaceutical Exports (Million US$) 2009 & 2010

Figure 5-91: Indonesia - Pharmaceutical Imports (Million US$) 2009 & 2010

Figure 5-92: Indonesia - Share of Branded & Generic Drugs in Pharmaceutical Market (2008)

Figure 5-93: Indonesia - Share of Top Players in Prescription Pharmaceutical Market, YTD 12 2010

Figure 5-94: Indonesia - Share of Top Players in OTC Pharmaceutical Market (YTD 12 2010)

List of Tables:

Table 3-1: Global - Pharmaceutical Market by Region (Billion US$), 2010

Table 4-1: E7 Countries - Disposable Income (Million US$), 2010 & 2014

Table 4-2: G7 Countries - Population (Million), 2010 & 2014

Table 4-3: E7 Countries - Population (Million), 2010 & 2014

Table 4-4: G7 Countries - Population in the Age Group of 65 Years & Above (Million), 2010 & 2014

Table 4-5: E7 Countries - Population in the Age Group of 65 Years & Above (Million), 2010 & 2014

Table 5-1: Brazil - Share of Top 10 Players in Pharmaceutical Market (2010)

Table 5-2: Russia - Top 10 Pharmaceutical Players by Sales (Million Rubles), 2010

Table 5-3: India - Top 10 Pharmaceutical Players by Sales (Million US$), 2010

Table 6-1: India, China & Brazil - Vaccine Market (Million US$), 2011 & 2013

Table 8-1: GlaxoSmithKline - Strengths & Weaknesses

Table 8-2: Sanofi-Aventis - Strengths & Weaknesses

Table 8-3: Pfizer Inc. - Strengths & Weaknesses

Table 8-4: Novartis - Strengths & Weaknesses

Table 8-5: AstraZeneca - Strengths & Weaknesses

To order this report:

Pharmaceutical Industry: Emerging Pharmaceutical Markets Globally

More  Market Research Report

Check our  Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Abaxis, Inc. to Present at Sidoti & Companys New York II Emerging Growth Institutional Investor Forum
2. Global Trend in Diabetes Could Exact Catastrophic Toll on Emerging Global Healthcare Systems
3. China Biologic Nominated for the 2011 Scrip Award as Best Company in an Emerging Market
4. Key Trends in Offshoring Pharmaceutical R&D: Company Strategies, Emerging Markets and Impact on ROI
5. Emerging Medical Devices Technology Trends - 2011
6. Endoscopy Devices Market in Emerging Economies (India, China, Brazil) - Growing Investments in Hospitals to be the Major Growth Driver
7. ClinStar to Present on Clinical Trial Recruitment in the Emerging Regions of Russia and Eastern Europe
8. Study Highlights Emerging Approaches to Medical Education in the Pharmaceutical Sector
9. Diabetes Care Devices: Emerging Countries (China, India, Brazil) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016
10. Continuous Glucose Monitors: Evolving Technology, Emerging Opportunities
11. Emerging Pharmaceutical Market in China - Forecast to Become The Worlds Third-Largest Pharmaceutical Market By 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... Jan. 20, 2017  Palladian Health, a leading ... the launch of an opioid management program which ... opioids and helps stem the growing tide of ... to treat chronic non-cancer pain (back pain, neck ... and lack of evidence regarding long-term effectiveness. ...
(Date:1/20/2017)... 2017 Avillion LLP, a co-developer and financier ... Weinberg , MD MBA as Chief Medical Officer. Dr Weinberg will ... . ... Weinberg has spent more than 17 years as a pharmaceutical and ... micro-cap biotech. Over the course of his career, he has interfaced ...
(Date:1/19/2017)... Jan. 19, 2017 Report Details ... Which areas are going to grow at the fastest ... 2026, assessing data, trends, opportunities and prospects. Our ... the most lucrative areas in the industry and the ... forecasted sales across the all the major categories of ...
Breaking Medicine Technology:
(Date:1/20/2017)... Viejo, California (PRWEB) , ... January 20, 2017 , ... ... easy to use inside of Final Cut Pro X," said Christina Austin - CEO ... on the RED Dragon. Utilizing the Dragon Sensor,TransFlare 4K Mystique lens flare and light ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Angel”: a heartwarming and earnest tale ... each of his children. “The Angel” is the creation of published author, Marjorie Lund-Fontaine, ... City, and impassioned writer. , When asked of her new book, Marjorie says, “‘The ...
(Date:1/20/2017)... ... January 20, 2017 , ... ... Positive Expiratory Pressure (OPEP) device, was featured in a study indicating superior performance ... RRT-ACCS, FAARC, “Analysis of Three Oscillating Positive Expiratory Pressure Devices During Simulated ...
(Date:1/20/2017)... ... , ... “Knowledge is God’s Lighthouse”: a moving and colorful collection of ... the creation of published author, Gene Gaapf, a retired truck driver, and a long-time ... been writing since high school and have many different titles,” Gaapf mentions about his ...
(Date:1/19/2017)... ... 20, 2017 , ... Today, the Centers for Medicare & Medicaid Services (CMS) ... Payment Models (APMs) in 2017. Clinicians who participate in APMs are paid for the ... of the Administration’s effort to build a system that delivers better care and one ...
Breaking Medicine News(10 mins):